Equity Analysis /
United States of America

US : Apellis Pharmaceuticals, Inc. - APLS | Analyzing Today's Solid 18-Month GA Dataset

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    25 March 2022
    Published by